Melatonin-Mepha 2 mg, Retardtabletten
7680686810020
CH-68681
Tabletten
Associated product:
MELATONIN Mepha cpr ret 2 mg bte 100 pce
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
80.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68681
- Drug name
- Melatonin-Mepha, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05CH01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 11/08/2022
- Authorization expiration date
- 10/08/2027
- IT Number
- 01.03.1.
- Domain
- Human medicine
Package details
- Description (FR)
- MELATONIN Mepha cpr ret 2 mg bte 100 pce
- Description (DE)
- MELATONIN Mepha Ret Tabl 2 mg Ds 100 Stk
- Market launch
- 11/08/2022
- Narcotic (BTM)
- No
Other package sizes (1)
MELATONIN Mepha cpr ret 2 mg 21 pce
21 TABL
GTIN: 7680686810013